Precision BioSciences Presents Late-Breaking Data Highlighting Preclinical Efficacy and Safety of PBGENE-HBV for Chronic Hepatitis B at AASLD's The Liver Meeting 2023Business Wire • 11/13/23
Precision BioSciences Announces Late-Breaking Poster Presentation at the American Association for the Study of Liver Diseases (AASLD) Annual MeetingBusiness Wire • 11/09/23
Precision BioSciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateBusiness Wire • 11/07/23
Precision BioSciences Presents Preclinical Data Highlighting Capabilities of ARCUS for Gene Insertion and Excision at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual CongressBusiness Wire • 10/26/23
Precision BioSciences to Present at Upcoming H.C. Wainwright 4th Annual Hepatitis B Virus ConferenceBusiness Wire • 10/23/23
Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual CongressBusiness Wire • 10/12/23
Precision BioSciences Receives U.S. Patent Allowance Covering PBGENE-PMM for m.3243-Associated Mitochondrial DiseasesBusiness Wire • 09/27/23
Precision BioSciences Hosts Virtual R&D Day Highlighting its Proprietary ARCUS Technology and Recent In Vivo Gene Editing Program DevelopmentsBusiness Wire • 09/12/23
Precision BioSciences to Attend and Present at Upcoming September Investor ConferencesBusiness Wire • 09/06/23
Precision BioSciences to Host In Vivo Gene Editing R&D Day on September 12, 2023Business Wire • 08/31/23
After Plunging -27.45% in 4 Weeks, Here's Why the Trend Might Reverse for Precision BioSciences (DTIL)Zacks Investment Research • 08/18/23
Precision BioSciences Completes Strategic Transaction with Imugene for Azer-Cel in CancerBusiness Wire • 08/15/23
Precision BioSciences (DTIL) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/04/23
Precision BioSciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateBusiness Wire • 08/04/23
Precision BioSciences Provides Updates on Azer-Cel FDA Meeting, Potential Partnerships and Timing of In Vivo R&D DayBusiness Wire • 07/27/23
Precision Biosciences: Plenty Of Positive Updates; Waiting For The Market To NoticeSeeking Alpha • 07/24/23
Precision BioSciences Announces Oral Presentation of Positive ARCUS® Gene Editing Data at International Liver Congress 2023Business Wire • 06/22/23
Precision BioSciences Provides Update on Allogeneic CAR T Programs and Regulatory Path ForwardBusiness Wire • 05/31/23
Precision BioSciences to Provide an Update on its Allogeneic CAR T Programs via Hosted Virtual Webcast and Conference Call on May 31, 2023Business Wire • 05/25/23
Precision BioSciences to Participate in Upcoming Stifel Genetic Medicines DayBusiness Wire • 05/24/23